LMNL-6511

N/A

Report date: 2025/01/26 18:12:06
NME

Base Information

Drug NameLMNL-6511
Drug Alias NameGPR84 antagonist (Liminal BioSciences)LMNL-6511
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 84 antagonists
TargetsG-protein coupled receptor 84
Therapy Area/IndicationsInflammationFibrosisMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLiminal Biosciences Inc
Inactive CompaniesN/A
Active IndicationsInflammationFibrosisMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A